Sales rise 12.36% to Rs 131.01 crore
Net profit of Natco Pharma declined 19.34% to Rs 11.72 crore in the quarter ended March 2013 as against Rs 14.53 crore during the previous quarter ended March 2012. Sales rose 12.36% to Rs 131.01 crore in the quarter ended March 2013 as against Rs 116.60 crore during the previous quarter ended March 2012.For the Audited full year,net profit rose 25.75% to Rs 78.13 crore in the year ended March 2013 as against Rs 62.13 crore during the previous year ended March 2012. Sales rose 22.73% to Rs 525.34 crore in the year ended March 2013 as against Rs 428.03 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales131.01116.60 12 525.34428.03 23 OPM %25.9725.49 2 29.8726.04 15 PBDT28.3624.37 16 143.7497.92 47 PBT23.0020.59 12 123.9082.51 50 NP11.7214.53 -19 78.1362.13 26
Powered by Capital Market - Live News
